Skip to main content
Premium Trial:

Request an Annual Quote

Gentel, Bio-Rad Laboratories

Premium
GenTel last week launched the APiX GlycoBiomarker Array Kit for multiplex profiling of glycans on serum glycoproteins.
 
The kit is based on technology licensed from the Van Andel Research Institute and contains an antibody microarray engineered to capture specific glycoproteins of interest from serum samples and to detect glycan patterns using biotinylated lectins.The kit features chemical derivitization of the immobilized capture antibodies that prevents non-specific binding of the lectins to glycans.
 

 
Bio-Rad Laboratories last week introduced the Bio-Rad iMark absorbance microplate reader and the Bio-Rad xMark absorbance microplate spectrophotometer. The company also released the Microplate Manager 6 software to operate the new readers and analyze data.
 
The iMark is designed for routine colorimetric assays in microplate format, such as ELISA, protein quantitation, and cell proliferation assays, the company said. The xMark is for absorbance spectrophotometry applications such as protein spectral detection colorimetric assays, and compounds and cell screening.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.